FiercePharma6d
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. | Revenues in the biopharma industry continued to boom ...
Managed Healthcare Executive5d
Lilly Lowers Prices of Some Zepbound Doses for Self-Pay Patients
The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Beam Therapeutics (BEAM)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on United Therapeutics (UTHR – Research Report) and ...
Reuters11d
Trump to meet pharma leaders as they seek drug policy changes
Feb 19 (Reuters) - U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White ...
devdiscourse9d
Health Headlines: Global Pharmaceutical Moves and Policy Changes
The health sector is facing significant changes, with the FDA restricting language, New York suing e-cigarette makers, AstraZeneca expanding in China, Eli Lilly stockpiling weight-loss drugs, Teva and ...